|
C1ORF43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.41580147184595E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.69053659959673E-12 |
| Normal-vs-Stage2 |
3.170600E-04 |
| Normal-vs-Stage3 |
9.360800E-03 |
| Normal-vs-Stage4 |
6.192000E-01 |
| Stage1-vs-Stage2 |
2.710600E-01 |
| Stage1-vs-Stage3 |
2.006100E-02 |
| Stage1-vs-Stage4 |
6.20359999999875E-05 |
| Stage2-vs-Stage3 |
2.848800E-01 |
| Stage2-vs-Stage4 |
3.723800E-02 |
| Stage3-vs-Stage4 |
2.329200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47759590621399E-11 |
| Normal-vs-AfricanAmerican |
1.86800019896793E-10 |
| Normal-vs-Asian |
1.483830E-01 |
| Caucasian-vs-AfricanAmerican |
6.898000E-01 |
| Caucasian-vs-Asian |
8.259200E-01 |
| AfricanAmerican-vs-Asian |
6.852600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.45168338355961E-13 |
| Normal-vs-Female |
3.41579999996178E-06 |
| Male-vs-Female |
1.722120E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.75939999996966E-06 |
| Normal-vs-Extreme_Weight |
2.07955874742538E-12 |
| Normal-vs-Obese |
6.61429999659902E-08 |
| Normal-vs-Extreme_Obese |
4.26009999999755E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.030320E-02 |
| Normal_Weight-vs-Obese |
5.488000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.830600E-01 |
| Extreme_Weight-vs-Obese |
6.729900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.331600E-01 |
| Obese-vs-Extreme_Obese |
6.300000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.890190E-02 |
| Normal-vs-Age(41-60Yrs) |
8.41130498585585E-11 |
| Normal-vs-Age(61-80Yrs) |
5.56277246488435E-12 |
| Normal-vs-Age(81-100Yrs) |
7.38600000049772E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.340200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.568000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.089200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.149600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.026400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.602600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62680979798324E-12 |
| Normal-VS-Type2 PRCC |
1.516960E-03 |
| Normal-VS-KIRP CIMP |
3.050200E-01 |
| Normal-VS-Unclassified PRCC |
3.86449999778549E-08 |
| Type1 PRCC-VS-Type2 PRCC |
1.67879999901643E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.000100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.312640E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.388800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.114210E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.986100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.67700000003524E-07 |
| Normal-vs-N1 |
8.605400E-01 |
| Normal-vs-N2 |
7.126800E-01 |
| N0-vs-N1 |
3.444300E-02 |
| N0-vs-N2 |
2.845600E-02 |
| N1-vs-N2 |
7.331400E-01 |
|
|
